Abstract:Ethnopharmacological relevance Liver fibrosis is a serious complication of liver disease characterized by excessive collagen deposition, without effective therapeutic agents in the clinic. Fu-Gan-Wan (FGW) is an empirical formula used for the clinical treatment of hepatitis and cirrhosis. It has been shown to reverse experimental liver fibrosis. However, its corresponding mechanisms remain unclear. Aim of the review This study aimed to elucidate the key pathways and target genes of FGW in attenuating liver fibrosis. Materials and methods The therapeutic effects of different doses of FGW on liver fibrosis were investigated using a 2 mL/kg 15% CCl 4 -induced mouse model. Then, RNA-seq combined with network pharmacology was used to analyze the key biological processes and signaling pathways underlying the anti-liver fibrosis exertion of FGW. These findings were validated in a TGF-β1-induced model of activation and proliferation of mouse hepatic stellate cell line JS-1. Finally, the key signaling pathways and molecular targets were validated using animal tissues, and the effect of FGW on tissue lipid peroxidation was additionally observed. Results We found that 19.5 g/kg FGW significantly down-regulated CCl 4 -induced elevation of hepatic ALT and AST, decreased collagen deposition, and inhibited the expression of pro-fibrotic factors α-SMA, COL1α1, CTGF, TIMP-1, as well as pro-inflammatory factor TGF-β1. Additionally, FGW at doses of 62.5, 125, and 250 μg/mL dose-dependently blocked JS-1 proliferation, migration, and activation. Furthermore, RNA-seq identified the NF-κB signaling pathway as a key target molecular pathway for FGW against liver fibrosis, and network pharmacology combined with RNA-seq focused on 11 key genes. Significant changes were identified in CCL2 and HMOX1 by tissue RT-PCR, Western blot, and immunohistochemistry. We further demonstrated that FGW significantly attenuated CCl 4 -induced increases in p-p65, CCL2, CCR2, and HMOX1, while significantly elevating Nrf2. Finally, FGW significantly suppressed the accumulation of lipid peroxidation products MDA and 4-HNE and reconfigured the oxidation-reduction balance, including promoting the increase of antioxidants GPx, GSH, and SOD, and the decrease of peroxidation products ROS and GSSG. Conclusions This study demonstrated that FGW exhibits potential in mitigating CCl 4 -induced hepatic fibrosis, lipid peroxidation, and iron metabolism disorders in mice. This effect may be mediated through the NF-κB/CCL2/CCR2 and Nrf2/HMOX1 pathways.

Oxysophoridine inhibits oxidative stress and inflammation in hepatic fibrosis via regulating Nrf2 and NF-κB pathways

ROS-dependent inhibition of the PI3K/Akt/mTOR signaling is required for Oroxylin A to exert anti-inflammatory activity in liver fibrosis

Resolving hepatic fibrosis via suppressing oxidative stress and an inflammatory response using a novel hyaluronic acid modified nanocomplex

Anti-inflammation Effects of Oxysophoridine on Cerebral Ischemia–Reperfusion Injury in Mice

Oroxylin A activates ferritinophagy to induce hepatic stellate cell senescence against hepatic fibrosis by regulating cGAS-STING pathway

Oxy210, a novel inhibitor of hedgehog and TGF‐β signalling, ameliorates hepatic fibrosis and hypercholesterolemia in mice

Forsythiaside A Regulates Activation of Hepatic Stellate Cells by Inhibiting NOX4-Dependent ROS

Doxofylline ameliorates liver fibrosis by regulating the ferroptosis signaling pathway

Suppression of SIRT1/FXR signaling pathway contributes to oleanolic acid-induced liver injury

Efficacy of Oroxylin A in Ameliorating Renal Fibrosis with Emphasis on Sirt1 Activation and TGF-β/Smad3 Pathway Modulation

An RORα agonist, ODH-08, inhibits fibrogenic activation of hepatic stellate cells via suppression of SMAD3

Resveratrol Alleviates Hepatic Fibrosis in Associated with Decreased Endoplasmic Reticulum Stress-Mediated Apoptosis and Inflammation

Anti-Fibrosis Effects Of Huisheng Oral Solution In Ccl4-Induced Hepatic Fibrosis In Rat

RNA-seq combined network pharmacology reveals that Fu-Gan-Wan (FGW) inhibits liver fibrosis via NF-κB/CCL2/CCR2 and lipid peroxidation via Nrf2/HMOX1 signaling pathway

Oxidative stress promotes liver fibrosis by modulating the microRNA-144 and SIN3A-p38 pathways in hepatic stellate cells

Targeting Oxidative Stress for the Treatment of Liver Fibrosis

Effect of Oxysophoridine on Expression of TNF-α and COX-2 in Carbon Tetrachloride Induced Acute Liver Injury in Mice

Oroxylin A Induces Apoptosis of Activated Hepatic Stellate Cells Through Endoplasmic Reticulum Stress.

A Bioinformatic and Mechanistic Study Elicits the Antifibrotic Effect of Ursolic Acid Through the Attenuation of Oxidative Stress with the Involvement of ERK, PI3K/Akt, and P38 MAPK Signaling Pathways in Human Hepatic Stellate Cells and Rat Liver

Anti-Inflammatory Oxysterol, Oxy210, Inhibits Atherosclerosis in Hyperlipidemic Mice and Inflammatory Responses of Vascular Cells

Interaction Mechanisms Between the NOX4/ROS and RhoA/ROCK1 Signaling Pathways As New Antifibrosis Targets of Ursolic Acid in Hepatic Stellate Cells